Skip to content
2000
  • ISSN: 1568-0169
  • E-ISSN: 1875-6174

Abstract

Phytoestrogenic molecules have received a great deal of attention over the last few years because of their potentially preventive roles against a few of today's most prevalent chronic diseases, namely cardiovascular diseases, osteoporosis and hormone related cancers. Of the several phytoestrogens, genistein in particular has been shown to be the most efficacious in animal models and experimental studies. Genistein in vitro relaxes rat arteries by a nitric oxide dependent mechanism and enhances the dilator response to acetylcholine of atherosclerotic arteries. Genistein supplementation improves endothelial dysfunction induced by oophorectomy in rats and reduces infarct size in an experimental model of myocardial ischaemia-reperfusion injury. Furthermore, genistein in postmenopausal women increases plasma nitric oxide breakdown products, reduces endothelin-1 levels and improves endothelial dependent vasodilation in post-menopausal women. All these findings, taken together, would suggest that this molecule might represent an attractive alternative for cardiovascular protection.

Loading

Article metrics loading...

/content/journals/cmccha/10.2174/1568016043477297
2004-04-01
2025-09-23
Loading full text...

Full text loading...

/content/journals/cmccha/10.2174/1568016043477297
Loading

  • Article Type:
    Review Article
Keyword(s): cardiovascular diseases; genistein; phytoestrogen; postmenopausal women
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test